title: The Fc receptor for IgG (Fc gamma RII; CD32) on human neonatal B lymphocytes.
abstract: B cells express an Fc receptor for IgG (FcgammaRII; CD32) which is involved in feedback inhibition of antibody production. Engagement of FcgammaRII during ligation of the antigen receptor provides an inhibitory signal. FcgammaRII exists as several isoforms, with FcgammaRIIb (which carries an immunoreceptor tyrosine-based inhibition motif; ITIM) being predominant form on adult B cells. The inhibitory role of FcgammaRIIb may be unhelpful to the infant, since primary exposure to infectious agents is likely to be in the presence of maternal IgG. We hypothesized that neonatal B cells would be less susceptible to feedback inhibition by antibody, either through the expression of activation-competent FcgammaRII isoforms (FcgammaRIIa and FcgammaRIIc) or through reduced expression of the inhibitory FcgammaRIIb isoforms. Cord and adult B cells were examined for expression of FcgammaRII isoforms using monoclonal antibodies and RT-PCR. In vitro assays were performed to assess susceptibility of cord and adult cells to FcgammaRII-mediated suppression. Although there is no phenotypic difference in FcgammaRII expression (FcgammaRIIb predominating on both adult and cord B cells), FcgammaRIIb is expressed at lower levels on cord cells. This quantitative difference in FcgammaRIIb expression may explain the reduced susceptibility of cord B cells to antibody-mediated inhibition observed in these experiments.
authors: Child Health Research Institute, Womens and Childrens Hospital, 5006, North Adelaide SA, Australia.
authors: C F
authors: CF
authors: Jessup
authors: J
authors: J
authors: Ridings
authors: A
authors: A
authors: Ho
authors: S
authors: S
authors: Nobbs
authors: D M
authors: DM
authors: Roberton
authors: P
authors: P
authors: Macardle
authors: H
authors: H
authors: Zola
mesh_terms: D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000502:physiology; D000911:Antibodies, Monoclonal / Q000502:physiology; D016175:B-Lymphocyte Subsets / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D005312:Fetal Blood / Q000276:immunology* / Q000378:metabolism*; D006131:Growth Inhibitors / Q000502:physiology; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000502:physiology; D007075:Immunoglobulin M / Q000276:immunology; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007231:Infant, Newborn; D008213:Lymphocyte Activation / Q000276:immunology; D020033:Protein Isoforms / Q000096:biosynthesis / Q000235:genetics; D017452:Receptors, IgG / Q000096:biosynthesis* / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D006131:Growth Inhibitors; D007140:Immunoglobulin Fab Fragments; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D020033:Protein Isoforms; D017452:Receptors, IgG; C044203:anti-IgM